Critical Reviews in Oncology / Hematology
Volume 74 , Pages S16-S17 , April 2010

Bisphosphonates in the adjuvant treatment of early breast cancer: conclusion

  • Wolfgang Eiermann

      Affiliations

    • Corresponding Author InformationCorrespondence: Prof. Dr. med. Wolfgang Eiermann. Medical director, Frauenklinik vom Roten Kreuz, Taxisstr. 3, 80637 München, Germany

References 

  1. Gnant M , Eidtmann H . The anti-tumor effect of bisphosphonates -ABCSG-12, ZO-FAST and more … . Crit Rev Oncol Hematol . 2010;74(1):S2–S6
  2. Diel I , Aebi S . Routine adjuvant use of bisphosphonates in breast cancer – Arguments in favour and against . Crit Rev Oncol Hematol . 2010;74(1):S11–S15

PII: S1040-8428(10)70006-8

doi: 10.1016/S1040-8428(10)70006-8

Critical Reviews in Oncology / Hematology
Volume 74 , Pages S16-S17 , April 2010